Pressure on pharmaceutical prices expected to persist
NEW YORK — Pricing pressures have become the new normal for the pharmaceutical industry. Three main factors are forcing down drug prices: government pressure, patent losses and the rise of generics. In developed markets, governments account for nearly 76% of spending on hospitals and other medical services. As a result, rising government measures to curb
